Dr Alison Fielding Chief Technology Officer Alison was the Chief Operating Officer of Techtran Group when it was acquired by IP Group in January 2005. Previously, she spent five years at McKinsey & Co where she consulted primarily to the pharmaceutical and health care sectors. Prior to McKinsey, Alison spent four years as a development chemist for Zeneca, performing technical roles in the speciality chemicals and agrochemicals divisions. ip2ipo
IP Group’s core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. www.ip2ipo.com/ipo/about/directors/
IP Group’s core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. www.ip2ipo.com/ipo/about/directors/exec/
Dr Alison Fielding Chief Technology Officer Alison was the Chief Operating Officer of Techtran Group when it was acquired by IP Group in January 2005. www.ip2ipo.com/ipo/about/directors/executive/
IP Group’s core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. www.ip2ipo.com/ipo/about/directors/physical_sciences/
Dr Alison Fielding Chief Technology Officer Alison was the Chief Operating Officer of Techtran Group when it was acquired by IP Group in January 2005. www.ip2ipo.com/ipo/about/directors/life_science/
